Investigation of Schwann cells at neoplastic cell sites before the onset of cancer invasion

IE Demir, A Boldis, PL Pfitzinger, S Teller… - Journal of the …, 2014 - academic.oup.com
IE Demir, A Boldis, PL Pfitzinger, S Teller, E Brunner, N Klose, T Kehl, M Maak, M Lesina…
Journal of the National Cancer Institute, 2014academic.oup.com
Background In neural invasion (NI), cancer cells are classically assumed to actively invade
nerves and to cause local recurrence and pain. However, the opposite possibility, that
nerves may reach cancer cells even in their preinvasive stage and thereby promote cancer
spread, has not yet been genuinely considered. The present study analyzes the reaction of
Schwann cells of peripheral nerves to carcinogenesis in pancreatic cancer and colon
cancer. Methods Two novel 3D migration and Schwann cell outgrowth assays were …
Background
In neural invasion (NI), cancer cells are classically assumed to actively invade nerves and to cause local recurrence and pain. However, the opposite possibility, that nerves may reach cancer cells even in their preinvasive stage and thereby promote cancer spread, has not yet been genuinely considered. The present study analyzes the reaction of Schwann cells of peripheral nerves to carcinogenesis in pancreatic cancer and colon cancer.
Methods
Two novel 3D migration and Schwann cell outgrowth assays were developed to monitor the timing and the specificity of Schwann cell migration and cancer invasion toward peripheral neurons through digital-time-lapse microscopy and after blockade of nerve growth factor (NGF) signalling via siRNA or a small-molecule inhibitor of the p75NTR receptor. The frequency and emergence of the Schwann cell markers Sox10, S100, ALDH1L1, and glial-fibrillary-acidic-protein (GFAP) around cancer precursor lesions were studied in human and conditional murine pancreatic and colon cancer specimens using multiple immunolabeling.
Results
Schwann cells migrated toward pancreatic and colon cancer cells, but not toward benign cells, before the onset of cancer migration toward peripheral neurons. This chemoattraction was inhibited after blockade of p75NTR-signaling on Schwann and pancreatic cancer cells. Schwann cells were specifically detected around murine and human pancreatic intraepithelial neoplasias (PanINs) (mean percent of murine PanINs surrounded by Schwann cells = 78.9%, 95% CI = 70.9 to 86.8%, and mean percent of human PanINs surrounded by Schwann cells = 52.5%, 95% CI = 14.7 to 90.4%; human: n = 44, murine: n = 14) and intestinal adenomas (mean percent of murine adenomas surrounded by Schwann cells = 64.2%, 95% CI = 28.6 to 99.8%, and mean percent of human adenomas surrounded by Schwann cells = 17.2%, 95% CI = -126.9 to 161.4; human: n = 36, murine: n = 12). The Schwann cell presence in this premalignant stage was associated with the frequency of NI in the malignant phase.
Conclusions
Schwann cells have particular and specific affinity to cancer cells. Emergence of Schwann cells in the premalignant phase of pancreatic and colon cancer implies that, in contrast with the traditional assumption, nerves—and not cancer cells—migrate first during NI.
Oxford University Press